
LOS ANGELES, July 13 (UPI) -- The AIDS Healthcare Foundation in Los Angeles has thanked the U.S. Food and Drug Administration for approving a new single-pill AIDS treatment.
The organization said the new drug, which combines three different AIDS drugs made by drug companies Bristol-Myers Squibb and Gilead, will make it much easier for AIDS patients to stick to their drug regimens.
"We thank the FDA for its historic approval ... of this new all-in-one AIDS drug treatment regimen," said Michael Weinstein, the foundation's president. "This joint venture between Gilead and Bristol-Myers Squibb is a milestone in the advancement of AIDS treatment and it also now sets a new, high watermark as an example of corporate -- and community-minded -- cooperation,"
"This new combined all-in-one AIDS treatment regimen will greatly reduce pill burden -- the number of pills an individual must take to control his or her HIV disease -- so it should greatly enhance patient adherence and compliance. It is our hope that this all-in-one regimen can also be quickly approved for and utilized in many global AIDS treatment programs around the world."
|
|
|
|
|
|
| Additional Science News Stories | |
WASHINGTON, May 31 (UPI) --
The U.S. House Thursday rejected a bill that would outlaw abortions based on gender, with abortion opponents promising to make the vote an election issue.
|
NEW YORK, May 31 (UPI) --
Actor Michael McKean, who was hit by a car last week while walking in New York, says he has been discharged from St. Luke's Hospital.
|
BALTIMORE, May 31 (UPI) --
U.S. astronomers are forecasting the Milky Way will have a violent collision with the neighboring Andromeda galaxy in about 4 billion years.
|
CLEVELAND, May 31 (UPI) --
Cleveland prosecutors have dropped their case against a man who was ticketed for littering when he dropped a dollar he was attempting to give a disabled person.
|
| Stories | Photos | People | Comments |
View Caption